Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer. It inhibits cancer cell growth and promotes cell death. Its clinical relevance lies in managing specific breast cancer types. In summary, Trastuzumab is essential for treating HER2-positive breast cancer.
Trastuzumab binds to the HER2 receptor, inhibiting signaling pathways that promote cancer cell proliferation.



